[Treatment of hypertensive insulin-resistant patients is a difficult decision to make. Metabolically neutral drugs should be the choice of treatment]

MeSH terms

• Aged
• Antihypertensive Agents / therapeutic use
• Clinical Trials as Topic
• Decision Making
• Diabetes Mellitus, Type 2 / drug therapy*
• Diabetes Mellitus, Type 2 / etiology
• Humans
• Hypertension / complications
• Hypertension / drug therapy*
• Insulin Resistance
• Middle Aged
• Risk Factors
• Scandinavian and Nordic Countries